Liver health and drug processing: a new study on tirabrutinib
NCT ID NCT07198087
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 30 times
Summary
This study looks at how the drug tirabrutinib moves through the body in people with mild, moderate, or severe liver problems compared to those with healthy livers. About 40 adults aged 18 to 75 will take part. The goal is to understand how liver function affects drug levels and safety, which helps doctors decide on proper dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Arizona Liver Health
Chandler, Arizona, 85225, United States
-
Orlando Clinical Research Center, Inc.
Orlando, Florida, 32809, United States
-
Panax Clinical Research
Miami Lakes, Florida, 33014, United States
Conditions
Explore the condition pages connected to this study.